Research Chemical Designation & Liability
Compounds indexed in the MinMaxMuscle archive are strictly for laboratory research and development. They are NOT approved for human consumption. Theoretical dosing data is aggregated from clinical literature and must not be construed as medical instruction. Professional medical consultation is mandatory prior to any research application.
Selank
Cognitive & Nootropic
Molecular Dossier
- Rank Index: 18
- Status: Pending Reclassification
- What does this mean?
- Molecular Structure: Heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro)
About Selank
Synthetic analog of the natural immune peptide Tuftsin; researched for anxiolytic, nootropic, and immune-modulating properties. As of the FDA's February 2026 regulatory shift announced by HHS Secretary RFK Jr., Selank is among the ~14 peptides expected to move from Category 2 (restricted) back to Category 1 compounding status. The formal ruling is pending the July 23–24, 2026 PCAC committee meeting. Until then, Selank remains Research Use Only (RUO) for laboratory investigation.
Clinical Focus
Anxiolytic & Immune Support
Archival Aliases
Anti-Anxiety Peptide, Tuftsin
Frequently Asked Questions
What are the strict legal and safety limitations for research-grade peptides?
All products listed in this research database are intended solely for laboratory research purposes and are not for human or animal consumption, diagnostic, or therapeutic use. As a researcher, it is your responsibility to ensure that all experimental protocols comply with local and federal regulations. These compounds are provided in lyophilized form to maintain chemical stability and must be handled by qualified professionals in a controlled environment. Any use outside of a supervised laboratory setting is strictly prohibited and violates the intended research application of these materials.
What are the potential risks of improper peptide handling in a research environment?
Improper handling of peptides can lead to rapid degradation, loss of potency, or chemical contamination. Exposure to high temperatures, direct sunlight, or physical agitation (shaking the vial) can break the delicate peptide bonds, rendering the research sample useless for data collection. Furthermore, using non-sterile solvents or failing to maintain a cold chain during transport can introduce bacterial pathogens. Researchers must prioritize aseptic techniques and precise reconstituting protocols to ensure the integrity of the experimental results and the longevity of the research material.
What distinguishes Selank from classical anxiolytics?
Selank regulates the metabolism of monoamines (serotonin, dopamine, norepinephrine) in the brain. Unlike benzodiazepines, which cause sedation and withdrawal, Selank exhibits anxiolytic effects while simultaneously improving cognitive focus and memory, classifying it as a "nootropic anxiolytic."
What is selank and how does it relate to tuftsin?
Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed at the Russian Academy of Sciences' Institute of Molecular Genetics. It is derived from tuftsin, a naturally occurring tetrapeptide that modulates immune function and has anxiolytic properties. Selank adds a Pro-Gly-Pro tripeptide tail that dramatically improves its stability and extends its duration of action. It is approved as a prescription anxiolytic in Russia.
How does selank reduce anxiety without sedation?
Unlike benzodiazepines (which broadly potentiate GABA-A receptors causing sedation), selank modulates GABA metabolism more subtly — it increases the expression of GABA-A receptor subunits and normalizes GABAergic tone without producing direct sedation. It also modulates dopamine, serotonin, and norepinephrine levels in the limbic system. The net effect is reduced anxiety and improved emotional stability with clear-headedness preserved.
What is the cognitive enhancement profile of selank?
Selank upregulates BDNF expression in hippocampal neurons, enhancing long-term potentiation and memory consolidation. It improves working memory performance in both animal and human studies, with some clinical data showing improvements equivalent to mild cognitive enhancers. Unlike stimulants, the cognitive benefit is characterized as improved focus and learning rather than increased arousal, making it suitable for use during complex cognitive tasks.
How does selank modulate the immune system?
As a tuftsin derivative, selank activates tuftsin receptors on macrophages and lymphocytes, enhancing phagocytosis and natural killer cell activity. Clinical trials in Russia document improvements in cellular immunity markers in patients with anxiety disorders (who often show suppressed immune function). This immune-enhancing action is considered a key differentiator of selank from purely synthetic anxiolytics.
What is the difference between selank and semax?
Both are Russian neuropeptides with intranasal delivery and overlapping cognitive benefits. Semax (ACTH-derived) primarily elevates BDNF and acts more strongly as a cognitive enhancer and neuroprotectant. Selank (tuftsin-derived) has stronger anxiolytic effects and more pronounced immune modulation. In the "Cognitive Focus" stack, they are combined because they address different aspects of mental performance — semax for focus/BDNF, selank for anxiety reduction — without significant pharmacological overlap.
What are selank's effects on cytokines?
Selank has been shown to reduce levels of pro-inflammatory cytokines (IL-6, TNF-alpha) while supporting IL-2 production, which drives T-cell proliferation. This anti-inflammatory cytokine profile is thought to contribute to its anxiolytic effects, as neuroinflammation is increasingly recognized as a driver of anxiety and depression. The dual anti-inflammatory and immune-supportive profile is unusual among anxiolytic compounds.
Is selank physically addictive?
No published evidence suggests selank causes physical dependence or withdrawal. Unlike benzodiazepines, it does not significantly downregulate GABA-A receptors with chronic use in studies to date. Russian clinical protocols have used selank continuously for months without documented tolerance or withdrawal. This is one of its most clinically attractive properties compared to conventional anxiolytics. Psychological patterns of use should still be monitored in any research context.
Clinical Data Matrix
| Parameter | Clinical Value |
|---|---|
| Molecular Weight | Heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) |
| Primary Pathway | Cognitive & Nootropic |
| Research Phase | Pending Reclassification |
Clinical Pros
- Highly selective receptor modulation
- Documented efficacy in Phase II trials
- Minimal systemic cross-reactivity
Research Limitations
- Limited long-term human data
- Strict storage and reconstitution requirements
- Potential for acute homeostatic feedback loops
Community Discussion
Share your questions and experiences with other researchers in the forum.
Discuss in ForumClinical Reference Nodes
Data Verified: 2026-05-31 10:51:59